Pharmaron Beijing Co., Ltd.

OTCPK:PHBB.F Stock Report

Market Cap: US$4.7b

Pharmaron Beijing Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:PHBB.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Oct 24SellUS$9,421,443JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,483,263US$2.10
09 Oct 24BuyUS$894,721JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany418,941US$2.14
06 Mar 24SellUS$1,173,204Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Securities & Investments ArmCompany796,109US$1.47
06 Mar 24SellUS$343,189Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany232,880US$1.47
05 Feb 24SellUS$85,304JP Morgan Asset ManagementCompany72,300US$1.18
05 Feb 24SellUS$5,791JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,908US$1.18
02 Feb 24BuyUS$1,176,252JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany994,343US$1.18
31 Jan 24SellUS$582,043JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany441,250US$1.32
29 Jan 24BuyUS$2,929,875JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,106,893US$1.39

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PHBB.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders138,457,0627.79%
Private Companies205,877,59111.6%
VC/PE Firms305,326,46417.2%
General Public345,512,27319.4%
Institutions782,612,61944%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.2%
Citic M&A Fund Management Co., Ltd.
305,326,464US$802.8m0%99.36%
17.2%
CITIC Securities Company Limited, Asset Management Arm
305,326,464US$802.8m0%8.48%
10.2%
Pharmaron Holdings Limited
180,496,500US$474.6m0%no data
5.66%
Xiaoqiang Lou
100,675,076US$264.7m0%no data
5.27%
Zhong Ou Fund Management Co., Ltd
93,679,981US$246.3m-0.24%1.18%
2.12%
Bei Zheng
37,706,986US$99.1m-40.2%no data
2.1%
E Fund Management Co., Ltd.
37,390,996US$98.3m0%0.17%
1.74%
GF Fund Management Co., Ltd.
31,013,665US$81.5m0%0.21%
1.47%
Hwabao WP Fund Management Co., Ltd
26,125,361US$68.7m3.63%0.61%
1.32%
Beijing Legend Tongdao Investment Consulting Partnership Enterprise (Limited Partnership)
23,535,557US$61.9m0%no data
1.11%
China Merchants Fund Management Company Ltd.
19,738,390US$51.9m0%0.29%
1.1%
China Universal Asset Management Company Ltd.
19,500,107US$51.3m0%0.14%
1%
Fullgoal Fund Management Co. Ltd.
17,775,006US$46.7m0%0.15%
0.87%
Huatai-PineBridge Fund Management Co., Ltd.
15,398,934US$40.5m0%0.1%
0.85%
HSBC Jintrust Fund Management Company Limited
15,059,200US$39.6m0%1.12%
0.83%
The Vanguard Group, Inc.
14,709,057US$38.7m33.8%no data
0.82%
HuaAn Fund Management Company Ltd.
14,616,497US$38.4m0%0.21%
0.64%
BlackRock, Inc.
11,326,551US$29.8m1.01%no data
0.52%
Tianhong Asset Management Co., Ltd.
9,318,813US$24.5m0%0.16%
0.49%
JPMorgan Chase & Co, Brokerage and Securities Investments
8,717,212US$22.9m81.8%0.01%
0.49%
Morgan Stanley, Investment Banking and Brokerage Investments
8,706,255US$22.9m24.2%no data
0.49%
Yinhua Fund Management Co., Ltd.
8,704,554US$22.9m0%0.19%
0.36%
First State Cinda Fund Management Company Limited
6,344,590US$16.7m0%0.4%
0.35%
China Asset Management Co. Ltd.
6,281,449US$16.5m1.42%0.02%
0.33%
Penghua Fund Management Co., Ltd.
5,955,105US$15.7m0%0.07%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/11 05:21
End of Day Share Price 2024/05/14 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharmaron Beijing Co., Ltd. is covered by 26 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Linda LuBOCI Research Ltd.
Yang LuoBOCI Research Ltd.
Bo LiBofA Global Research